Cantel Medical Corp. (NYSE:CMN) saw unusually-high trading volume on Monday . Approximately 284,735 shares changed hands during trading, an increase of 92% from the previous session’s volume of 148,075 shares.The stock last traded at $69.67 and had previously closed at $68.98.

The stock has a market capitalization of $2.88 billion and a PE ratio of 50.97. The stock’s 50 day moving average price is $68.11 and its 200-day moving average price is $66.97.

Cantel Medical Corp. (NYSE:CMN) last issued its quarterly earnings results on Wednesday, June 8th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.08. During the same period in the previous year, the business posted $0.35 earnings per share. The firm had revenue of $173.70 million for the quarter, compared to the consensus estimate of $163.16 million. The business’s revenue for the quarter was up 22.8% compared to the same quarter last year. On average, analysts forecast that Cantel Medical Corp. will post $1.44 EPS for the current year.

The company also recently declared a semiannual dividend, which was paid on Friday, July 29th. Shareholders of record on Friday, July 15th were paid a dividend of $0.06 per share. This represents a yield of 0.17%. The ex-dividend date of this dividend was Wednesday, July 13th.

In other Cantel Medical Corp. news, COO Jorgen B. Hansen sold 2,000 shares of the stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $72.44, for a total transaction of $144,880.00. Following the completion of the transaction, the chief operating officer now directly owns 41,383 shares of the company’s stock, valued at approximately $2,997,784.52. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Eric W. Nodiff sold 2,574 shares of the stock in a transaction on Friday, June 10th. The shares were sold at an average price of $72.97, for a total value of $187,824.78. Following the transaction, the executive vice president now directly owns 53,084 shares of the company’s stock, valued at $3,873,539.48. The disclosure for this sale can be found here.

A number of institutional investors have recently modified their holdings of CMN. State of Tennessee Treasury Department purchased a new position in shares of Cantel Medical Corp. during the fourth quarter worth about $1,709,000. California Public Employees Retirement System increased its stake in shares of Cantel Medical Corp. by 4.0% in the fourth quarter. California Public Employees Retirement System now owns 93,200 shares of the company’s stock worth $5,791,000 after buying an additional 3,600 shares during the period. Principal Financial Group Inc. increased its stake in shares of Cantel Medical Corp. by 4.3% in the fourth quarter. Principal Financial Group Inc. now owns 242,720 shares of the company’s stock worth $15,082,000 after buying an additional 10,052 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Cantel Medical Corp. by 3.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,377,481 shares of the company’s stock worth $85,598,000 after buying an additional 48,527 shares during the period.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.